Publications by authors named "David Charytan"

Claim this Profile
A
Approach to Quality Control Used for the HOPE Consortium Trial to Reduce Pain and Opioid Use in Hemodialysis.
Sagar U Nigwekar, Laura M Dember, Sahir Kalim, David M Charytan, Natalie Kuzla

Clin J Am Soc Nephrol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Fall Risk in Maintenance Hemodialysis Patients: A Secondary Analysis of the HOPE Consortium Trial.
David M Charytan, Alvin H Moss, Manar Shalak, Wenbo Wu, Laura M Dember

Clin J Am Soc Nephrol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fish Oil for Patients Receiving Hemodialysis - Red Herring or Great Catch?
Finnian R Mc Causland, David M Charytan

N Engl J Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic Pain Locations, Characteristics, and Associations With Other Symptoms in Adults Receiving Maintenance Hemodialysis: Findings From the HOPE Consortium Trial.
Michael J Fischer, Jesse Y Hsu, Joanna Walsh, Kerri L Cavanaugh, David M Charytan

Am J Kidney Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Class 1 Indications for Coronary Revascularization Identified in Prekidney Transplant Screening.
Avantika Israni, Bronya L Sandorffy, Celina S Liu, Daniela I Fraticelli Ortiz, Haley M Gross, David M Charytan

J Am Soc Nephrol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 Pandemic-induced Healthcare Disruption and Chronic Kidney Disease Progression.
Richard Liu, Rahul Abraham, Sarah E Conderino, Rania Kanchi, Saul B Blecker, David M Charytan

J Gen Intern Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Moderate Kidney Dysfunction Independently Increases Sudden Cardiac Arrest Risk: A Community-Based Study.
Thien Tan Tri Tai Truyen, Audrey Uy-Evanado, Harpriya Chugh, Kyndaron Reinier, David M Charytan

J Am Heart Assoc· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Requiem for mineralocorticoid blockade in maintenance dialysis.
Qandeel H Soomro, David M Charytan

Lancet· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SGLT2 Inhibitors and Risk for Hyperkalemia Among Individuals Receiving RAAS Inhibitors.
Sara Wing, Joel G Ray, Kevin Yau, Nivethika Jeyakumar, Sheikh Abdullah, David Charytan

JAMA Intern Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fall Risk in Maintenance Hemodialysis Patients: A Secondary Analysis of the HOPE Consortium Trial.
David M Charytan, Alvin H Moss, Manar Shalak, Wenbo Wu, Laura M Dember

Clin J Am Soc Nephrol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neighborhood Built Environment and Home Dialysis Utilization: Varying Patterns by Urbanicity-Dependent Patterns and Implications for Policy.
Byoungjun Kim, Yiting Li, Myeonggyun Lee, Sunjae Bae, Matthew F Blum, David M Charytan

Am J Kidney Dis· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Effects of dialysate potassium concentration of 3.0 mmol/l with sodium zirconium cyclosilicate on dialysis-free days versus dialysate potassium concentration of 2.0 mmol/l alone on rates of cardiac arrhythmias in hemodialysis patients with hyperkalemia." Kidney International 2025;107:169-179.
David M Charytan, Wolfgang C Winkelmayer, Christopher B Granger, John P Middleton, Charles A Herzog

Kidney Int· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GLP-1 Receptor Agonist Outcomes, Safety, and Body Mass Index Change in a National Cohort of Patients on Dialysis.
Babak J Orandi, Yusi Chen, Yiting Li, David Charytan, Krista L Lentine

Clin J Am Soc Nephrol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intradialytic Cognitive and Aerobic Exercise Training to Preserve Cognitive Function: IMPCT, a Multi-Dialysis Center 2 × 2 Factorial Block-Randomized Controlled Trial.
Nidhi Ghildayal, Yi Liu, Jingyao Hong, Yiting Li, Xiaomeng Chen, David M Charytan

Am J Nephrol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular, kidney and safety outcomes with canagliflozin in older adults: A combined analysis from the CANVAS Program and CREDENCE trial.
Amanda Siriwardana, Luke Buizen, Min Jun, Sradha Kotwal, Clare Arnott, David M Charytan

Diabetes Obes Metab· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of Ambulatory Kidney Supportive Care in a Safety Net Hospital.
Jennifer S Scherer, Radhika J Gore, Annette Georgia, Susan E Cohen, Nina Caplin, David Charytan

J Pain Symptom Manage· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pilot randomized controlled study of integrated kidney palliative care and chronic kidney disease care implemented in a safety-net hospital: Protocol for a pilot study of feasibility of a randomized controlled trial.
Jennifer S Scherer, Wenbo Wu, Chen Lyu, Keith S Goldfeld, Abraham A Brody, David Charytan

Contemp Clin Trials Commun· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial.
Kenneth W Mahaffey, Katherine R Tuttle, Mustafa Arici, Florian M M Baeres, George Bakris, David M Charytan

Eur Heart J· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Moderate Kidney Dysfunction Independently Increases Sudden Cardiac Arrest Risk: A Community-Based Study.
Thien Tan Tri Tai Truyen, Audrey Uy-Evanado, Harpriya Chugh, Kyndaron Reinier, David M Charytan

medRxiv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pain Coping Skills Training for Patients Receiving Hemodialysis: The HOPE Consortium Randomized Clinical Trial.
Laura M Dember, Jesse Y Hsu, Rajnish Mehrotra, Kerri L Cavanaugh, Sahir Kalim, David M Charytan

JAMA Intern Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of dialysate potassium concentration of 3.0 mmol/l with sodium zirconium cyclosilicate on dialysis-free days versus dialysate potassium concentration of 2.0 mmol/l alone on rates of cardiac arrhythmias in hemodialysis patients with hyperkalemia.
David M Charytan, Wolfgang C Winkelmayer, Christopher B Granger, John P Middleton, Charles A Herzog

Kidney Int· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gender Differences in Citation Rate: An Analysis of Randomized Controlled Trials in Nephrology High-Impact Journals Over Two Decades.
Qandeel H Soomro, Shuojohn Li, Angela McCarthy, Dalila Varela, Javaughn Ways, Amalya M Charytan, David M Charytan

Clin J Am Soc Nephrol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alzheimer Disease-Related Biomarkers in Patients on Maintenance Hemodialysis.
Arjun V Masurkar, Nisha Bansal, David K Prince, Wolfgang C Winkelmayer, Daniela F Ortiz, David M Charytan

Kidney Med· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Dialysate Bicarbonate with Arrhythmia in the Monitoring in Dialysis Study.
Katherine Scovner Ravi, James A Tumlin, Prabir Roy-Chaudhury, Bruce A Koplan, Alexandru I Costea, David M Charytan

Kidney360· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial.
Glenn M Chertow, Anna Marie Chang, G Michael Felker, Mark Heise, Elena Velkoska, David M Charytan

Nat Med· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis